Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen
OwnerIra Sandersinventor
Life of this patent
Estimating the term…
Abstract
A method is disclosed for blocking or reducing physiological reaction in a mammal to the interaction of IgE antibodies present in said mammal upon contact with the corresponding antigen, by the administration to said mammal of a therapeutically effective amount of a neurotoxin (CnT) derived from Clostridia sp.
Claims12
1-24. (canceled)
A method of treating infectious rhinitis comprising administering a therapeutically effective amount of a neurotoxin (CnT) derived from a species of Clostridia to a mammal suffering from infectious rhinitis, wherein the infectious rhinitis is treated.
A method of reducing the inflammation associated with infectious rhinitis comprising administering a therapeutically effective amount of a neurotoxin (CnT) derived from a species of Clostridia to a mammal suffering from inflammation associated with infectious rhinitis, wherein the inflammation is reduced.
A method of preventing infectious rhinitis comprising administering a therapeutically effective amount of a neurotoxin (CnT) derived from a species of Clostridia to a mammal at risk for suffering from infectious rhinitis, wherein the infectious rhinitis is prevented.
Dependencies are inferred from the claim text.